Financial statements Pluspharma
Cash flow statement of Pluspharma
Company age:
Age:
11 y. 8 m. 18 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of PLUSPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -445 091,21 | 2 031 556,18 | -526 758,40 | 6 100 438,05 | 5 423 205,70 | 1 981 174,20 |
| Net cash flow from investing activities | 401 537,76 | -102 376,26 | -76 177,28 | -189 069,47 | -446 072,16 | -526 252,83 |
| Net cash flow from financial activities | -29 088,03 | -1 990 306,73 | 527 938,75 | -5 859 403,76 | -4 701 106,96 | -518 965,59 |
| Total net cash flow | -72 641,48 | -61 126,81 | -74 996,93 | 51 964,82 | 276 026,58 | 935 955,78 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.